TRIM10 and acute myeloid leukemia: Among AML cell lines, the adriamycin-resistant cell line K562/ADR showed lower protein (p = 0.047, Figure 2B) and mRNA (p = 0.035, Figure 2C) levels of TRIM10 than its parent cell line K562, indicating that TRIM10 may play an important role in AML drug resistance.